Showing results for "#US pharma Pfizer’s antiviral Paxlovid"

Covid rebound in 1 in 5 after Pfizer’s antiviral Paxlovid: Study

Reassuringly, there was no evidence that the virus is developing resistance to the medication among patients with rebound